Showing results (161-170 of 201) with videos related to

Sort By:
Pageof 21
Human Molecular Genetics|December 1, 2007
Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9pHelen M Broadbent, John F Peden, Stefan Lorkowski, et al.
Lancet (London, England)|November 8, 2005
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control studySalim Yusuf, Steven Hawken, Stephanie Ounpuu, et al.
European Heart Journal|November 1, 2001
Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chartR Marchioli, F Avanzini, F Barzi, et al.
Circulation|May 18, 2011
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trialJohn W Eikelboom, Lars Wallentin, Stuart J Connolly, et al.
Expert Review of Cardiovascular Therapy|July 11, 2009
Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trialRoberto Marchioli, Giacomo Levantesi, Maria G Silletta, et al.
Plos Genetics|May 20, 2006
Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17Martin Farrall, Fiona R Green, John F Peden, et al.
American Heart Journal|February 15, 2011
Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trialAndrea A Finzi, Roberto Latini, Simona Barlera, et al.
Circulation. Cardiovascular Imaging|September 20, 2011
Left atrial remodeling and response to valsartan in the prevention of recurrent atrial fibrillation: the GISSI-AF echocardiographic substudyLidia Staszewsky, Maylene Wong, Serge Masson, et al.
Lancet (London, England)|January 13, 2015
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials, Jordan Fulcher, Rachel O'Connell, et al.
Heart (British Cardiac Society)|October 23, 2010
Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trialSerge Masson, Aneta Aleksova, Chiara Favero, et al.
Pageof 21